lobbying_filings_raw: ddca8b4f-bb5c-40d8-93a0-e9b17e11b9ca
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ddca8b4f-bb5c-40d8-93a0-e9b17e11b9ca | Q1 | 312576 | AMERICAN CANCER SOCIETY, CALIFORNIA DIVISION, INC. | 183995 | AMERICAN CANCER SOCIETY CALIFORNIA DIVISION INC | 2012 | first_quarter | 2012-04-19T16:56:41.317000-04:00 | 360000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/ddca8b4f-bb5c-40d8-93a0-e9b17e11b9ca/", "filing_uuid": "ddca8b4f-bb5c-40d8-93a0-e9b17e11b9ca", "filing_type": "Q1", "filing_type_display": "1st Quarter - Report", "filing_year": 2012, "filing_period": "first_quarter", "filing_period_display": "1st Quarter (Jan 1 - Mar 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/ddca8b4f-bb5c-40d8-93a0-e9b17e11b9ca/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "360000.00", "expenses_method": "b", "expenses_method_display": "Method B - Reporting amounts under section 6033(b)(8) of the Internal Revenue Code", "posted_by_name": "Allen Lum, Real Estate Manager/Tax Accountant", "dt_posted": "2012-04-19T16:56:41.317000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": "United States of America", "registrant_address_1": "1710 WEBSTER STREET", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "OAKLAND", "registrant_state": "CA", "registrant_zip": "94612", "registrant": {"id": 312576, "url": "https://lda.senate.gov/api/v1/registrants/312576/", "house_registrant_id": 38757, "name": "AMERICAN CANCER SOCIETY, CALIFORNIA DIVISION, INC.", "description": null, "address_1": "1710 WEBSTER STREET", "address_2": null, "address_3": null, "address_4": null, "city": "OAKLAND", "state": "CA", "state_display": "California", "zip": "94612", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "ALLEN LUM", "contact_telephone": "", "dt_updated": "2022-04-06T16:06:36.044665-04:00"}, "client": {"id": 183995, "url": "https://lda.senate.gov/api/v1/clients/183995/", "client_id": 12, "name": "AMERICAN CANCER SOCIETY CALIFORNIA DIVISION INC", "general_description": null, "client_government_entity": false, "client_self_select": true, "state": "CA", "state_display": "California", "country": "US", "country_display": "United States of America", "ppb_state": "CA", "ppb_state_display": "California", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2007-08-14"}, "lobbying_activities": [{"general_issue_code": "TOB", "general_issue_code_display": "Tobacco", "description": "Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) legislation regarding Congressional review/approval of regulations, including H.R. 10, the Regulations from the Executive in Need of Security Act of 2011; (4) Framework Convention on Tobacco Control (FCTC); and (5) issues relating to NIH reorganization. Legislation includes H.R. 3186 and S. 1706, Smuggled Tobacco Prevention Act; H.R. 3382, Smoke-Free Federal Building Act; S. 1403, IDEA Full Funding Act; And H.R. 65: Candy Tobacco Tax Parity Act of 2011.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 17612, "prefix": null, "prefix_display": null, "first_name": "KEVIN", "nickname": null, "middle_name": null, "last_name": "KEANE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Issues relating to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R. 2941 and S. 3493; HR 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; HR 4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Protection and Affordable Care Act of 2010; S. 1064, the Sun Act; S. 965, the Family Act; HR 2954, Health Equity and Accountability Act of 2011; and HR 2077, the MLR Repeal Act; H.R. 2245 and S. 296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, and issues relating to the ongoing national shortage of cancer drugs.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 17612, "prefix": null, "prefix_display": null, "first_name": "KEVIN", "nickname": null, "middle_name": null, "last_name": "KEANE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid, including S. 868 and H.R. 1683, the State Flexibility Act (MOE); and matters under consideration by the Joint Select Committee on Deficit Reduction.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 17612, "prefix": null, "prefix_display": null, "first_name": "KEVIN", "nickname": null, "middle_name": null, "last_name": "KEANE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, and international health; and matters under consideration by the Joint Select Committee on Deficit Reduction. Legislation includes H. Con. Res. 34, establishing the budget for the US Government for FY 2012; S. 1599, legislation including draft House text of legislation making appropriations for L-HHS FY 12; H.R. 2055 and S. 3671, Consolidated Appropriations Act of 2012.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 17612, "prefix": null, "prefix_display": null, "first_name": "KEVIN", "nickname": null, "middle_name": null, "last_name": "KEANE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |